Does GRASP affect DCE-MRI quantitative parameters and texture analysis in patients with esophageal cancer receiving preoperative neoadjuvant chemotherapy?

被引：0
|
作者：
Yanan Lu
Ling Ma
Zhaoqi Wang
Jia Guo
Hongkai Zhang
Xu Yan
Hui Liu
Ihab R. Kamel
Hailiang Li
Jianjun Qin
Jinrong Qu
机构：
[1] Affiliated Cancer Hospital of Zhengzhou University,Department of Radiology
[2] Henan Cancer Hospital,Advanced Application Team
[3] GE Healthcare,NEA MR Collaboration
[4] Siemens Ltd.,Department of Thoracic Surgery
[5] China,Department of Radiology
[6] Affiliated Cancer Hospital of Zhengzhou University,undefined
[7] Henan Cancer Hospital,undefined
[8] Johns Hopkins University School of Medicine,undefined
来源：
Chinese Journal of Academic Radiology | 2019年 / 1卷
关键词：
Magnetic resonance imaging; Esophageal cancer; Treatment outcome; Chemotherapy; Neoadjuvant therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 33
页数：8
相关论文
共 50 条
  • [31] Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapy
    Pickles, Martin D.
    Manton, David J.
    Lowry, Martin
    Turnbull, Lindsay W.
    EUROPEAN JOURNAL OF RADIOLOGY, 2009, 71 (03) : 498 - 505
  • [32] An approach to the prediction of breast cancer response to neoadjuvant chemotherapy based on tumor habitats in DCE-MRI images
    Carvalho, Edson Damasceno
    da Silva Neto, Otilio Paulo
    Mathew, Mano Joseph
    de Carvalho Filho, Antonio Oseas
    EXPERT SYSTEMS WITH APPLICATIONS, 2023, 234
  • [33] PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI
    Halim, M.
    Sreenivas, M.
    BREAST CANCER RESEARCH, 2014, 16
  • [34] Association of hematological inflammatory markers with texture features or volumetric parameters on FDG PET in patients with esophageal cancer receiving neoadjuvant chemotherapy and surgery
    Tatsumi, Mitsuaki
    Isohashi, Kayako
    Watabe, Tadashi
    Kato, Hiroki
    Hatazawa, Jun
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [35] Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?
    Uzun, Mehmet
    Atag, Elif
    Yildirim, Eda Caliskan
    Keser, Murat
    Semiz, Huseyin Salih
    Unal, Olcun Umit
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer
    Ken Nagasaka
    Hiroko Satake
    Satoko Ishigaki
    Hisashi Kawai
    Shinji Naganawa
    Breast Cancer, 2019, 26 : 113 - 124
  • [37] Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI
    Chen, Jeon-Hor
    Yu, Hon
    Lin, Muqing
    Mehta, Rita S.
    Su, Min-Ying
    MAGNETIC RESONANCE IMAGING, 2013, 31 (09) : 1465 - 1478
  • [38] PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI
    M Halim
    M Sreenivas
    Breast Cancer Research, 16
  • [39] Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer
    Nagasaka, Ken
    Satake, Hiroko
    Ishigaki, Satoko
    Kawai, Hisashi
    Naganawa, Shinji
    BREAST CANCER, 2019, 26 (01) : 113 - 124
  • [40] Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer
    Ma, Xiang-Zheng
    Lv, Kun
    Sheng, Jian-Liang
    Yu, Ying-Xing
    Pang, Pei-Pei
    Xu, Mao-Sheng
    Wang, Shi-Wei
    ONCOLOGY LETTERS, 2019, 17 (03) : 3077 - 3084
12345